DrugPatentWatch Database Preview
Ferrer Internacional Company Profile
What is the competitive landscape for FERRER INTERNACIONAL, and when can generic versions of FERRER INTERNACIONAL drugs launch?
FERRER INTERNACIONAL has one approved drug.
There are three US patents protecting FERRER INTERNACIONAL drugs.
Summary for Ferrer Internacional
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ferrer Internacional
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,399,014 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 6,335,447 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | 9,180,200 | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | |||
| Ferrer Internacional | XEPI | ozenoxacin | CREAM;TOPICAL | 208945-001 | Dec 11, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Ferrer Internacional Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2177208 | ➤ Try a Free Trial |
| European Patent Office | 1070713 | ➤ Try a Free Trial |
| Philippines | 12014502425 | ➤ Try a Free Trial |
| Spain | 2437967 | ➤ Try a Free Trial |
| South Korea | 101682256 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ferrer Internacional Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017000073 | Germany | ➤ Try a Free Trial | PRODUCT NAME: OZENOXACIN; NAT. REGISTRATION NO/DATE: 97303.00.00 20170803; FIRST REGISTRATION: BELGIEN BE509591 20170517 |
| 0884 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: OZENOXACIN; REGISTRATION NO/DATE: ES/H/414/1/DC 20170519 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
